Black Diamond Therapeutics, Inc. (BDTX) Tops Q1 EPS by 3c

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• WidePoint (WYY) Halted, News Pending
• Citi Upgrades Formosa Petrochemical Corp. (6505:TT) to Buy